Claudia Latch
Physician Assistant · Augusta, GANPI 1093914475
Payments from drug & device makers
Across 130 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$608
- Novo Nordisk$489
- Lilly USA, LLC$404
- Biohaven Pharmaceuticals, Inc.$280
- AbbVie$169
- GSK$140
- plus $620 from 12 others
What the payments were for
- Food & beverage$2,710100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $608 |
| Novo Nordisk | 30 | $489 |
| Lilly USA, LLC | 22 | $404 |
| Biohaven Pharmaceuticals, Inc. | 7 | $280 |
| AbbVie | 18 | $169 |
| GSK | 8 | $140 |
| Pfizer | 3 | $139 |
| Intuitive Surgical | 1 | $129 |
| Boehringer Ingelheim | 4 | $105 |
| Bayer | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| Exact Sciences | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$325
- Da Vinci Surgical System$129
- FARXIGA$109
How this compares
$2,710 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $16,382 |
| JardianceEmpagliflozin | 20 | $14,170 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $668 |
| Rosuvastatin Calcium | 36 | $399 |
| Doxycycline Hyclate | 42 | $359 |
| CefuroximeCefuroxime Axetil | 30 | $296 |
| Levothyroxine Sodium | 11 | $193 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 12 | $183 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $164 |
| Valsartan | 11 | $148 |
| Diclofenac Sodium | 16 | $116 |
| Atorvastatin Calcium | 15 | $111 |
| Prednisone | 31 | $73 |
| Metformin Hcl | 17 | $65 |
| Amlodipine Besylate | 24 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $404 | $16,38214 claims |
| Boehringer IngelheimJardiance | $105 | $14,17020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Augusta
- Jonell PoeAugusta$18K
- Julie BuirdAugusta$17K
- Kolyse CaverAugusta$16K
- Lacey PrestonAugusta$15K
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.